New Prostate Cancer Test From Genomic Health Reveals Positive Results in Recent Clinical Validation Study
News
Genomic Health, Inc., will present results from nine different studies of Oncotype DX®, a genomic-based diagnostic test, in prostate, breast, and renal cancers at the European Society for Medical Oncology (ESMO) ... Read more